AR047581A1 - CALCIVIRUS FELINO VACCINES - Google Patents

CALCIVIRUS FELINO VACCINES

Info

Publication number
AR047581A1
AR047581A1 ARP050100207A ARP050100207A AR047581A1 AR 047581 A1 AR047581 A1 AR 047581A1 AR P050100207 A ARP050100207 A AR P050100207A AR P050100207 A ARP050100207 A AR P050100207A AR 047581 A1 AR047581 A1 AR 047581A1
Authority
AR
Argentina
Prior art keywords
vaccine
feline calicivirus
nucleic acid
isolated
capsid protein
Prior art date
Application number
ARP050100207A
Other languages
Spanish (es)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AR047581A1 publication Critical patent/AR047581A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation

Abstract

Vacuna para inmunizar a un gato frente al calicivirus felino. Clon de ácido nucleico que codifica la proteína de la cápsida del calicivirus felino aislado. Vacuna viva o muerta que comprende el calicivirus felino aislado, una vacuna de subunidad que comprende la proteína de la cápsida del calicivirus felino aislado, una vacuna de ácido nucleico que comprende un clon de ácido nucleico de calicivirus felino aislado, y una vacuna de vector de virus recombinante que comprende un ácido nucleico que codifica la proteína de la cápsida del calicivirus felino aislado. Método para identificar un calicivirus util para producir una composicion de vacuna y para ensayos para diagnosticar a gatos infectados por el calicivirus felino. Método de tratamiento.Vaccine to immunize a cat against feline calicivirus. Nucleic acid clone encoding the isolated feline calicivirus capsid protein. Live or dead vaccine comprising the isolated feline calicivirus, a subunit vaccine comprising the isolated feline calicivirus capsid protein, a nucleic acid vaccine comprising an isolated feline calicivirus nucleic acid clone, and a vector vaccine of Recombinant virus comprising a nucleic acid encoding the isolated feline calicivirus capsid protein. Method to identify a useful calicivirus to produce a vaccine composition and for tests to diagnose cats infected by feline calicivirus. Treatment method

ARP050100207A 2004-01-20 2005-01-20 CALCIVIRUS FELINO VACCINES AR047581A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53768304P 2004-01-20 2004-01-20

Publications (1)

Publication Number Publication Date
AR047581A1 true AR047581A1 (en) 2006-01-25

Family

ID=34885937

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100207A AR047581A1 (en) 2004-01-20 2005-01-20 CALCIVIRUS FELINO VACCINES

Country Status (3)

Country Link
AR (1) AR047581A1 (en)
TW (1) TW200538153A (en)
WO (1) WO2005080416A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
CN103550767B (en) 2005-07-28 2017-04-19 硕腾服务有限责任公司 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
WO2017031120A1 (en) * 2015-08-20 2017-02-23 Merial, Inc. Fcv recombinant vaccines and uses thereof
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines
RU2018123480A (en) * 2015-12-23 2020-01-24 Интервет Интернэшнл Б.В. VACCINE AGAINST CAT-CALICIVIRUS
CN110272488B (en) * 2018-03-16 2022-05-17 洛阳普泰生物技术有限公司 Cat calicivirus monoclonal antibody and application thereof
CN112877297A (en) * 2021-03-27 2021-06-01 哈尔滨元亨生物药业有限公司 Method for preparing cat distemper virus monoclonal antibody by using bioreactor
CN113801243B (en) * 2021-09-27 2022-08-09 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Tandem expression of universal epitope of feline calicivirus GI and GII strains and establishment of indirect ELISA method thereof
CN114874997B (en) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） Cat cup virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2069742T3 (en) * 1989-07-21 1995-05-16 Upjohn Co PROTEIN OF FELINE CALICIVIRUS CAPSID AND NUCLEOTIDE SEQUENCE.
WO2000076538A1 (en) * 1999-06-10 2000-12-21 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof

Also Published As

Publication number Publication date
TW200538153A (en) 2005-12-01
WO2005080416A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
AR047581A1 (en) CALCIVIRUS FELINO VACCINES
ATE461710T1 (en) NIPAH VIRUS VACCINES
MXPA05009580A (en) Influenza virus vaccine.
NO20080046L (en) Methods for administering vaccine, new feline calicivirus, and treatments for immunizing animals against feline paraovirus and feline herpes virus
BRPI0923599A2 (en) recombinant classical swine fever virus, live classical swine fever vaccine, methods to protect an animal against classical swine fever, to differentiate animals infected with classical swine fever virus from uninfected animals or animals vaccinated with swine fever vaccine and to isolate an infectious recombinant classical swine fever virus, cdna molecule, use of the infectious recombinant classical swine fever virus, and, peptide-based elisa
WO2007024947A3 (en) Canine influenza vaccines
NZ735684A (en) Materials and methods for respiratory disease control in canines
EA201001045A1 (en) MODIFIED FLU VIRUS
AR056712A1 (en) COMPOSITION AND EFFECTIVE VACCINE TO TREAT TO PREVENT OR IMPROVE THE INOCULATION OF THE CANINE INFLUENZA VIRUS METHOD TO GENERATE AN IMMUNOGEN OF THE EQUINE INFLUENZA VIRUS OR OF THE VIRUS INFLUENZA MODEL OF THE USE OF THE CONTACT US TO DETERMINE THE COMPACT
CY1111521T1 (en) DOUBLE SYSTEM CALCULOUS CALCULUS
AR094725A1 (en) PARVOVIRUS 5A PORCINO, METHODS OF USE AND VACCINE
CY1112575T1 (en) IMPROVED FCV VACCINATED VACCINES
NO20056207L (en) Composition for vaccination of dogs
WO2011091389A3 (en) Cyclovirus and method of use
ATE507286T1 (en) IMMUNIZATION OF FISH AGAINST VIRUS INFECTION
MX2021012695A (en) Csfv subunit vaccine.
AR067439A1 (en) ANTIGENIC CHEMICAL VIRUSES OF ST. LOUIS / VIRUS DENGUE TYPE 4
BRPI0822947A2 (en) Recombinant vaccine, method for vaccination against animal diseases and method for identification between infected and vaccinated animals
EA200401505A1 (en) EXPRESSION OF GENES OF ANKARA MODIFIED OSPOVACCINE VIRUS WITH THE USE OF THE ATI-PROMOTOR OF THE COW OSH VIRUS
BR112012004847A2 (en) mutant bohv-4 genome, mutant bohv-4 virus, vaccine, use of a mutant bohv-4 virus, cell, method for producing a mutant bohv-4 genome or mutant bohv-4 virus, and diagnosis to differentiate infected animals.
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
DE602004019971D1 (en) COMBINATION VACCINE FOR POULTRY
DE60236943D1 (en) INDUCED IMMUNE RESPONSE AGAINST THE CAT IMMUNE WEAKEN VIRUS
WO2006101810A3 (en) Theileria parva dna vaccines
UA126846U (en) AVIVAK-IEKVM-2 - A Vaccine Associated Inactivated Against Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis and Infectious Diseases

Legal Events

Date Code Title Description
FB Suspension of granting procedure